Cytomx TherapeuticsCTMX
13F holders, Q4 2024 (December 31)70holders +1
8new positions
10sold out
4famous investors
$1.03avg. 13F price*
At the end of Q4 2024, 70 institutions reported holding Cytomx Therapeutics Inc. (CTMX) in their 13F filings, up 1 from Q3 2024. 8 opened new positions and 10 sold out. The largest holders were Tang Capital Management LLC ($7.5M), BVF Inc. ($5.4M) and Vanguard Group Inc. ($5.3M). 4 famous investors held it, including Steve Cohen (0.0% of Point72 Asset Management's portfolio), Israel Englander (0.0% of Millennium Management's portfolio) and Jim Simons / Peter Brown (0.0% of Renaissance Technologies's portfolio).
- Company
- Cytomx Therapeutics Inc.
- CUSIP
- 23284F105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 8 | $2.9M |
| Exits | 10 | $10.0M |
All 13F filers, Q3 2024 → Q4 2024: 6,893,464 shares bought and 11,769,253 shares sold, net −4,875,789 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 70 holders
| Tang Capital Management LLC | 0.50% | Reduce -6.4% | 7,311,760 | $7.5M |
| BVF Inc. | 0.18% | No change | 5,228,461 | $5.4M |
| Vanguard Group Inc. | 0.00% | No change | 5,162,302 | $5.3M |
| Prosight Management, LP | 1.13% | Add +29.2% | 3,905,000 | $4.0M |
| Millennium Management | 0.00% | Add +25.8% | 3,221,012 | $3.3M |
| Acadian Asset Management LLC | 0.01% | Add +1.2% | 3,137,046 | $3.2M |
| Point72 Asset Management | 0.01% | New | 2,650,000 | $2.7M |
| Jacobs Levy Equity Management, Inc. | 0.01% | Add +1.5% | 1,547,215 | $1.6M |
| Schonfeld Strategic Advisors LLC | 0.01% | Add +13.9% | 1,380,800 | $1.4M |
| Renaissance Technologies | 0.00% | Add +32.7% | 1,346,800 | $1.4M |
| Laurion Capital Management LP | 0.08% | No change | 1,248,364 | $1.3M |
| BlackRock, Inc. | 0.00% | Add +6.1% | 1,239,778 | $1.3M |
| Congress Park Capital LLC | 0.36% | Reduce -20.7% | 964,590 | $994K |
| Geode Capital Management, LLC | 0.00% | Add +1.5% | 815,643 | $840K |
| JPMorgan Chase & Co. | 0.00% | Add +288736.3% | 811,630 | $836K |
| Assenagon Asset Management S.A. | 0.00% | Reduce -63.5% | 599,850 | $618K |
| UBS Group AG | 0.00% | Add +635.6% | 508,556 | $524K |
| Sei Investments Co. | 0.00% | No change | 487,902 | $503K |
| Altium Capital Management LLC | 0.15% | Reduce -48.9% | 467,491 | $482K |
| Formidable Asset Management, LLC | 0.06% | Add +55.5% | 382,529 | $394K |
| Tidal Investments LLC | 0.00% | Add +55.5% | 382,529 | $394K |
| Monimus Capital Management, LP | 0.35% | — | 364,306 | $375K |
| Bridgeway Capital Management, LLC | 0.01% | Reduce -7.0% | 331,624 | $342K |
| Citadel Advisors | 0.00% | Add +1.6% | 322,311 | $332K |
| Two Sigma Investments, LP | 0.00% | Reduce -32.0% | 320,767 | $330K |
| State Street Corp. | 0.00% | Add +21.4% | 320,043 | $330K |
| FMR LLC | 0.00% | Add +7.9% | 306,783 | $316K |
| Connor, Clark & Lunn Investment Management Ltd. | 0.00% | Add +2.1% | 286,480 | $295K |
| Bank of New York Mellon Corp | 0.00% | Reduce 0.0% | 241,980 | $249K |
| Northern Trust Corp. | 0.00% | Add +16.0% | 150,632 | $155K |
| ADAR1 Capital Management, LLC | 0.03% | Reduce -84.0% | 145,036 | $149K |
| HRT Financial LP | 0.00% | Add +310.7% | 110,242 | $113K |
| Cubist Systematic Strategies, LLC | 0.00% | Add +302.2% | 98,383 | $101K |
| Prudential Financial Inc. | 0.00% | Add +76.2% | 64,300 | $66K |
| Forefront Analytics, LLC | 0.03% | Add +7.5% | 64,259 | $66K |
| Susquehanna International Group, LLP | 0.00% | Add +480.1% | 59,778 | $62K |
| Virtu Financial LLC | 0.00% | Reduce -35.6% | 57,012 | $59K |
| Qube Research & Technologies Ltd | 0.00% | No change | 55,108 | $57K |
| Commonwealth Equity Services, LLC | 0.00% | Reduce -1.8% | 53,243 | $55K |
| Private Advisor Group, LLC | 0.00% | Reduce -15.7% | 44,002 | $45K |
| LPL Financial LLC | 0.00% | Add +10.4% | 42,315 | $44K |
| Aspire Growth Partners LLC | 0.04% | — | 40,780 | $42K |
| Gsa Capital Partners LLP | 0.00% | New | 38,885 | $40K |
| Vanguard Personalized Indexing Management, LLC | 0.00% | New | 36,992 | $38K |
| Velan Capital Investment Management LP | 0.03% | New | 35,000 | $36K |
| Russell Investments Group, Ltd. | 0.00% | Reduce -28.5% | 34,054 | $35K |
| Algert Global LLC | 0.00% | New | 33,570 | $35K |
| XTX Topco Ltd | 0.00% | Reduce -24.6% | 32,922 | $34K |
| US Bancorp \de | 0.00% | Reduce -8.9% | 30,792 | $32K |
| Traphagen Investment Advisors LLC | 0.00% | New | 30,500 | $31K |
| Miller Financial Services LLC | 0.02% | — | 25,000 | $26K |
| Charles Schwab Investment Management Inc. | 0.00% | No change | 24,817 | $26K |
| Jane Street Group, LLC | 0.00% | Reduce -20.5% | 21,653 | $22K |
| WestHill Financial Advisors, Inc. | 0.00% | No change | 17,082 | $18K |
| Morgan Stanley | 0.00% | Reduce -73.8% | 13,201 | $14K |
| Nierenberg Investment Management Company, LLC | 0.01% | No change | 12,555 | $13K |
| IPG Investment Advisors LLC | 0.00% | No change | 12,500 | $13K |
| Peregrine Asset Advisers, Inc. | 0.00% | No change | 10,000 | $10K |
| Ikarian Capital, LLC | 0.00% | No change | 8,924 | $9K |
| Lazard Asset Management LLC | 0.00% | Reduce -37.6% | 5,505 | $5K |
| Group One Trading LLC | 0.00% | Reduce -14.0% | 4,224 | $4K |
| Tower Research Capital LLC (TRC) | 0.00% | Add +1275.2% | 3,273 | $3K |
| Bank of America Corp. | 0.00% | Reduce -90.2% | 2,021 | $2K |
| SBI Securities Co., Ltd. | 0.00% | — | 1,107 | $1K |
| Bollard Group LLC | 0.00% | No change | 712 | $1K |
| Osaic Holdings, Inc. | 0.00% | Reduce -3.3% | 870 | $896 |
| Bell Investment Advisors, Inc | 0.00% | New | 388 | $400 |
| Raleigh Capital Management Inc. | 0.00% | No change | 250 | $258 |
| BNP Paribas Financial Markets | 0.00% | Reduce -59.8% | 78 | $80 |
| Simplex Trading, LLC | 0.00% | New | 507 | $0 |
"% of holder's portfolio" is CTMX's weight in each manager's 13F, not the share of Cytomx Therapeutics Inc. the manager owns.